City
Epaper

LANXESS Q1 sales up 43.7 per cent to EUR 2.432 billion

By ANI | Published: May 11, 2022 5:08 PM

Specialty Chemicals company LANXESS made a strong start to the year 2022. In the first quarter of 2022, EBITDA pre exceptionals increased considerably and amounted to EUR 320 million, 32.2 per cent higher than the previous year's figure of EUR 242 million. All the company's segments contributed to the growth, with the Specialty Additives segment performing particularly well. LANXESS passed on the significantly increased raw material and energy costs via higher selling prices. The successful acquisitions, especially that of Emerald Kalama Chemical, likewise made a positive earnings contribution. The EBITDA margin pre exceptionals came to 13.2 per cent, against 14.3 per cent a year ago.

Open in App

Specialty Chemicals company LANXESS made a strong start to the year 2022. In the first quarter of 2022, EBITDA pre exceptionals increased considerably and amounted to EUR 320 million, 32.2 per cent higher than the previous year's figure of EUR 242 million. All the company's segments contributed to the growth, with the Specialty Additives segment performing particularly well. LANXESS passed on the significantly increased raw material and energy costs via higher selling prices. The successful acquisitions, especially that of Emerald Kalama Chemical, likewise made a positive earnings contribution. The EBITDA margin pre exceptionals came to 13.2 per cent, against 14.3 per cent a year ago.

Group sales amounted to EUR 2.432 billion in the first quarter, up 43.7 per cent on the previous year's figure of EUR 1.693 billion. Net income reached EUR 98 million, after net income from continuing operations of EUR 63 million in the previous year.

LANXESS is also confident going into the second quarter, in which the Group expects EBITDA pre exceptionals of between EUR 280 million and EUR 350 million. In the prior-year quarter, the company had generated EUR 277 million. For the full year, LANXESS still expects EBITDA pre exceptionals to be significantly higher than in the previous year. However, the guidance does not take into account potential further impacts of the war in Ukraine and the contribution of the acquisition of IFF's Microbial Control business. The transaction is expected to close in the third quarter.

"With our focus on speciality chemicals, we have built up strong market positions in recent years, which are particularly paying off in the current situation. We can thus pass on higher raw material and energy costs via our selling prices. However, it is impossible to predict the impact of the war in Ukraine on future business performance. We are therefore monitoring the further developments very closely," said Matthias Zachert, Chairman of the Board of Management of LANXESS AG.

This story is provided by PNN.will not be responsible in any way for the content of this article. (ANI/PNN)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: EbitdaLanxessMatthias zachert
Open in App

Related Stories

BusinessHDFC makes strategic investment in Bonito Designs

BusinessMaximus Group: Charting a path towards Rs 250 crore revenue by 2025

BusinessMaiden Forgings Ltd. Reports Splendid Net Profit Growth of 338.23% for FY23

BusinessPaytm clocks 35 pc merchant growth to Rs 2.65 lakh crore in Apr-May 2023

BusinessGenesys International records highest ever yearly revenue and PAT growth of 50 per cent and 146 per cent

Business Realted Stories

BusinessG20 Sherpa Amitabh Kant lauds India's digital transformation journey in 9 years

BusinessGST collection for May at Rs 1.73 lakh crore, up 10 per cent YoY

BusinessGST collection at Rs 1.73 lakh cr, falls in May compared to April but up 10 pc YoY

BusinessPF members can update or correct their profile data online: EPFO

BusinessAgniKul Cosmos in advance talks with 13 customers, says co-founder Srinath Ravichandran